Evidence map›Paper›PMID 42298302›Full record

ArticleCancer medicine2026

Metacognitions and Reproductive Concerns in Testicular Cancer Patients of Reproductive Age: The Mediating Role of Fear of Progression.

Ya Hu, Jie Zhou, CangMei Fu, YunLin Ye, Xia Zheng, HuiMing Lu, XiangDong Li, GuoLong Chen, Fen Liu, BaoYi Lai and 1 more

Abstract read
In one paragraph

Article in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ya HuDepartment of Urology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, China.ORCID https://orcid.org/0009-0008-4095-1536
Jie ZhouDepartment of Urology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, China.ORCID https://orcid.org/0009-0002-1642-1187
CangMei FuDepartment of Oncology, The Second Xiangya Hospital, Central South University, Changsha, China.ORCID https://orcid.org/0009-0008-6909-4056
YunLin YeDepartment of Urology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, China.ORCID https://orcid.org/0000-0001-5424-7066
Xia ZhengDepartment of Urology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, China.ORCID https://orcid.org/0009-0003-0157-1171
HuiMing LuDepartment of Urology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, China.ORCID https://orcid.org/0009-0004-6188-5890
XiangDong LiDepartment of Urology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, China.ORCID https://orcid.org/0000-0003-3375-8638
GuoLong ChenDepartment of Urology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, China.ORCID https://orcid.org/0009-0007-2088-9504
Fen LiuDepartment of Urology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, China.ORCID https://orcid.org/0009-0006-8789-4159
BaoYi LaiDepartment of Urology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, China.ORCID https://orcid.org/0009-0000-6780-2356
Xue FuDepartment of Urology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, China.ORCID https://orcid.org/0000-0002-4329-0015

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMany testicular cancer patients of reproductive age experience reproductive concerns. Metacognitions may alleviate patients' fear of progression and reproductive concerns. However, this relationship has not been well established in testicular cancer patients of reproductive age.

objectiveThis study examines the level of reproductive concerns and explores how fear of progression mediates the relationship between metacognitions and reproductive concerns in testicular cancer patients of reproductive age in China.

methodsThis study employed a quantitative cross-sectional design and was reported in accordance with the STROBE guidelines for observational research. A convenience sample of 192 testicular cancer patients of reproductive age was recruited from a tertiary specialized oncology hospital in Guangzhou, Guangdong, China. Data were collected through the WeChat mini program "Questionnaire Star" using "the general data questionnaire", the Metacognitions Questionnaire-30 (MCQ-30), the Fear of Progression Questionnaire-Short Form (FoP-Q-SF), and the Reproductive Concerns After Cancer-Male scale (RCAC-M) instruments. The data were analyzed using descriptive statistics, Pearson correlation analyses, and simple mediation effect analysis via the PROCESS macro program.

resultsReproductive concerns were at a moderate level (57.86 ± 10.93), and positively associated with metacognitions (r = 0.358, p < 0.001) and fear of progression (r = 0.523, p < 0.001). Mediation analysis revealed that metacognitions had a total effect path coefficient of 0.317 on reproductive concerns (bootstrap 95% CI: 0.202-0.432). The direct effect path coefficient was 0.152 (bootstrap 95% CI: 0.026-0.277), while the mediating effect through fear of progression was 0.166 (bootstrap 95% CI: 0.094-0.239), representing 52.4% of the total effect.

conclusionsIn testicular cancer patients of reproductive age, metacognitions are significantly associated with reproductive concerns, and fear of progression acts as a mediating factor. Interventions aimed at improving metacognition levels and reducing fear of progression may help alleviate reproductive concerns in this population.

Indexed as

FearTesticular NeoplasmsAdultChinaCross-Sectional StudiesDisease ProgressionHumansMaleMiddle AgedReproductionSurveys and QuestionnairesYoung Adultfear of progressionmediating rolemetacognitionsreproductive concernssperm cryopreservationtesticular cancer

Identifiers

PMID42298302
PMCPMC13269004

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.